| Toggle Summary
|
JPLs release copy of their Fifth Report to the Grand Court of the Cayman Islands
|
|
| Toggle Summary
|
JPLs release copy of their Fourth Report to the Grand Court of the Cayman Islands
|
|
| Toggle Summary
|
JPLs release copy of their Third Report to the Grand Court of the Cayman Islands
|
|
| Toggle Summary
|
JPLs release copy of their Second Report to the Grand Court of the Cayman Islands
|
|
| Toggle Summary
|
JPLs release copy of their First Report to the Grand Court of the Cayman Islands
|
|
| Toggle Summary
|
Press Release in respect of the JPLs appointment
|
|
| Toggle Summary
|
Global Cord Blood Corporation Files Annual Report on Form 20-F
|
|
| Toggle Summary
|
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM
|
|
| Toggle Summary
|
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
|
|
| Toggle Summary
|
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
|
|
| Toggle Summary
|
Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened
|
|
| Toggle Summary
|
Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition
|
|
| Toggle Summary
|
Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights
|
|
| Toggle Summary
|
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022
|
|
| Toggle Summary
|
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
|
|
